Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686423 · ClinicalTrials.gov registry record · NA
Reversing Diabetic Peripheral Neuropathy Through Exercise
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03686423 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 44 participants.
The verdict
NCT03686423, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This project proposes a longitudinal design that uses multinuclear-MRI to evaluate the mechanistic effects of exercise on skeletal muscle function and peripheral nerve integrity in patients with diabetic peripheral neuropathy (DPN), and to determine whether exercise can reverse DPN symptoms. The investigators will prescribe a 10-week exercise program to 40 DPN patients. The investigators will acquire multinuclear-MRI data before and after the intervention that can provide mechanistic insight into the adaptations in lower leg muscle function and peripheral nerve integrity of patients with DPN, and their role in improving DPN symptoms following physical exercise intervention.
Interventions
- PROCEDURE Exercise Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-11-28 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03686423
The ClinicalTrials.gov registry entry for NCT03686423 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise Program is the first listed.
NCT03686423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03686423 about?
NCT03686423 is a clinical study titled "Reversing Diabetic Peripheral Neuropathy Through Exercise". This project proposes a longitudinal design that uses multinuclear-MRI to evaluate the mechanistic effects of exercise on skeletal muscle function and peripheral nerve integrity in patients with diabetic peripheral neuropathy (DPN), and to determine whether exercise can reverse DPN symptoms. The inv...
What is the current status of trial NCT03686423?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2018-11-28. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03686423?
The interventions under investigation include: Exercise Program (PROCEDURE).
Who is sponsoring clinical trial NCT03686423?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.